U.S.: Market for Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses 2024

Market Size for Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses in the U.S.

The U.S. human and animal blood market soared to $X in 2022, increasing by X% against the previous year. The market value increased at an average annual rate of X% over the period from 2012 to 2022; however, the trend pattern remained relatively stable, with somewhat noticeable fluctuations being recorded throughout the analyzed period. As a result, consumption reached the peak level of $X. From 2014 to 2022, the growth of the market remained at a somewhat lower figure.

Production of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses in the U.S.

In value terms, human and animal blood production rose to $X in 2022. In general, production, however, continues to indicate a relatively flat trend pattern. The pace of growth appeared the most rapid in 2020 when the production volume increased by X%. Over the period under review, production hit record highs at $X in 2013; however, from 2014 to 2022, production failed to regain momentum.

Exports of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

Exports from the U.S.

After two years of growth, shipments abroad of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses decreased by X% to X tons in 2022. Over the period under review, exports, however, recorded a resilient expansion. The pace of growth was the most pronounced in 2017 with an increase of X%. The exports peaked at X tons in 2021, and then contracted notably in the following year.

In value terms, human and animal blood exports shrank rapidly to $X in 2022. Overall, exports, however, saw strong growth. The growth pace was the most rapid in 2017 when exports increased by X% against the previous year. Over the period under review, the exports attained the maximum at $X in 2021, and then dropped markedly in the following year.

Exports by Country

Canada (X tons) was the main destination for human and animal blood exports from the United States, accounting for a X% share of total exports. Moreover, human and animal blood exports to Canada exceeded the volume sent to the second major destination, Ireland (X tons), twofold. The UK (X tons) ranked third in terms of total exports with a X% share.

From 2012 to 2022, the average annual rate of growth in terms of volume to Canada totaled X%. Exports to the other major destinations recorded the following average annual rates of exports growth: Ireland (X% per year) and the UK (X% per year).

In value terms, Ireland ($X) remains the key foreign market for human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses exports from the United States, comprising X% of total exports. The second position in the ranking was taken by the UK ($X), with a X% share of total exports. It was followed by Japan, with a X% share.

From 2012 to 2022, the average annual rate of growth in terms of value to Ireland amounted to X%. Exports to the other major destinations recorded the following average annual rates of exports growth: the UK (X% per year) and Japan (X% per year).

Export Prices by Country

The average human and animal blood export price stood at $X per ton in 2022, surging by X% against the previous year. Over the period under review, the export price posted noticeable growth. The most prominent rate of growth was recorded in 2019 when the average export price increased by X% against the previous year. Over the period under review, the average export prices reached the maximum in 2022 and is likely to continue growth in years to come.

Prices varied noticeably by country of destination: amid the top suppliers, the country with the highest price was Ireland ($X per ton), while the average price for exports to Canada ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to Brazil (X%), while the prices for the other major destinations experienced more modest paces of growth.

Imports of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

Imports into the U.S.

In 2022, purchases abroad of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses decreased by X% to X tons, falling for the second consecutive year after three years of growth. Overall, imports showed a mild curtailment. The most prominent rate of growth was recorded in 2014 with an increase of X% against the previous year. As a result, imports reached the peak of X tons. From 2015 to 2022, the growth of imports failed to regain momentum.

In value terms, human and animal blood imports fell dramatically to $X in 2022. Over the period under review, imports faced a abrupt descent. The most prominent rate of growth was recorded in 2014 with an increase of X%. Imports peaked at $X in 2018; however, from 2019 to 2022, imports failed to regain momentum.

Imports by Country

Denmark (X tons), Germany (X tons) and the UK (X tons) were the main suppliers of human and animal blood imports to the United States, together accounting for X% of total imports. Switzerland, France, Italy, the Netherlands, China, Japan, Canada, Spain, New Zealand and India lagged somewhat behind, together accounting for a further X%.

From 2012 to 2022, the most notable rate of growth in terms of purchases, amongst the main suppliers, was attained by Spain (with a CAGR of X%), while imports for the other leaders experienced more modest paces of growth.

In value terms, the UK ($X) constituted the largest supplier of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses to the United States, comprising X% of total imports. The second position in the ranking was held by Germany ($X), with an X% share of total imports. It was followed by Switzerland, with a X% share.

From 2012 to 2022, the average annual rate of growth in terms of value from the UK totaled X%. The remaining supplying countries recorded the following average annual rates of imports growth: Germany (X% per year) and Switzerland (X% per year).

Import Prices by Country

In 2022, the average human and animal blood import price amounted to $X per ton, picking up by X% against the previous year. Over the period under review, the import price, however, recorded a abrupt downturn. The pace of growth was the most pronounced in 2017 an increase of X%. Over the period under review, average import prices attained the maximum at $X,259 per ton in 2012; however, from 2013 to 2022, import prices remained at a lower figure.

Prices varied noticeably by country of origin: amid the top importers, the country with the highest price was the UK ($X,939 per ton), while the price for Denmark ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by the UK (X%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :